The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of …
R Licordari, F Costa, V Garcia-Ruiz, MA Mamas… - Journal of Clinical …, 2024 - mdpi.com
Acute coronary syndromes (ACS), encompassing conditions like ST-elevation myocardial
infarction (STEMI) and non-ST-elevation acute coronary syndromes (NSTE-ACS), represent …
infarction (STEMI) and non-ST-elevation acute coronary syndromes (NSTE-ACS), represent …
Unused potential of lipid-lowering therapy in very high-risk patients with atherosclerotic cardiovascular disease. A retrospective data analysis
SB Pohl, C Engelbertz, H Reinecke, NM Malyar… - Nutrition, Metabolism …, 2024 - Elsevier
Background Atherosclerotic cardiovascular disease (ASCVD) is the most common cause of
death in Europe. Although the 2019 European Society of Cardiology/European …
death in Europe. Although the 2019 European Society of Cardiology/European …
What Is New in the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes
M Roffi - Cardiology Discovery, 2023 - mednexus.org
For the first time, European Society of Cardiology (ESC) guidelines have aggregated in 1
single document recommendations for the management of patients with non-ST-segment …
single document recommendations for the management of patients with non-ST-segment …
The Impact of Polypill on Adherence and Cardiovascular Outcomes: A Comprehensive Systematic Review with Meta-Analysis
Background: Cardiovascular disease (CVD) remains a leading cause of morbidity and
mortality worldwide. Polypills, containing various combinations of medications for primary …
mortality worldwide. Polypills, containing various combinations of medications for primary …
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the global burden of disease study 2021
KCD Mettananda, S Mettananda - 2024 - repository.kln.ac.lk
BACKGROUND Future trends in disease burden and drivers of health are of great interest to
policy makers and the public at large. This information can be used for policy and long-term …
policy makers and the public at large. This information can be used for policy and long-term …
[HTML][HTML] Is there a role for earlier use of combination therapy?
S Revankar, JK Park, P Satish, A Agarwala - American Journal of …, 2024 - Elsevier
As the global population ages and cardiovascular risk factors rise, we can expect a
continued increase in atherosclerotic disease. Low-density lipoprotein cholesterol (LDL-C) …
continued increase in atherosclerotic disease. Low-density lipoprotein cholesterol (LDL-C) …
The place of polypill in secondary prevention of stroke
DB Ojji, MD Huffman - The Lancet Global Health, 2023 - thelancet.com
People who have had a stroke are confronted with multiple medications and complex
treatment regimens, both associated with low adherence. As a result of barriers at the health …
treatment regimens, both associated with low adherence. As a result of barriers at the health …
Non-ST Elevation Myocardial Infarction in the Elderly. Antithrombotic Therapy and Beyond
P Díez-Villanueva, C Jiménez-Méndez… - … vol. 24, issue. 7, p. 201, 2023 - diposit.ub.edu
Non-ST segment elevation myocardial infarction (NSTEMI) is the most frequent type of acute
coronary syndrome in the elderly. Antithrombotic therapy is the cornerstone of …
coronary syndrome in the elderly. Antithrombotic therapy is the cornerstone of …
Health equity and actionable disparities in stroke: 2022 update
A Towfighi, B Ovbiagele - Stroke, 2023 - Am Heart Assoc
There are stark inequities in stroke incidence, prevalence, care, and outcomes. This issue of
Stroke features manuscripts from the third annual HEADS-UP (Health Equity and Actionable …
Stroke features manuscripts from the third annual HEADS-UP (Health Equity and Actionable …
Assessment of Medication Adherence Using Pharmacy Data Before and After Percutaneous Coronary Intervention
SM Abera, C O'Donnell, T Salahuddin… - Patient preference …, 2023 - Taylor & Francis
Objective Adherence to anti-platelet medications is critical following coronary stenting, but
prior studies indicate that clinician assessment and patient self-assessment of adherence …
prior studies indicate that clinician assessment and patient self-assessment of adherence …